See How In Vivo Microscopy Can Make Pathology Better, Faster & Cheaper
Fifth Annual
Digital Pathology
Transforming Medicine in a Digital Age
February 20-22, 2017 | Moscone North Convention Center | San Francisco, CA
Part of the 24th Annual Molecular Medicine Tri-Conference
Triconference.com/Digital-
Special Session on In Vivo Microscopy at Digital Pathology Conference in San Francisco
Join 3,500 Informatics, Diagnostics, Clinical, and Oncology Researchers at CHI’s Flagship Molecular Medicine Event! In Vivo microscopy represents an innovative area for the pathologist since it circumvents a tissue biopsy and allows real-time imaging of tissues using new imaging modalities that do not require processing. Validation is required to make this the gold standard for use by pathologists. Learn about newer, non-invasive techniques that will change current practices dramatically.
Naked Eye to Nucleotide
Babar K. Rao, M.D., FAAD, Clinical Professor, Dermatology, Robert Wood Johnson Medical School, Rutgers University
Histology is an accepted “gold standard” to manage most diseases. Newer non invasive, in vivo technologies are gaining popularity and are becoming routine tests in many specialities, especially skin. Confocal microscopy is one such tool which has potential to change dermatology practice drastically.
Ex vivo Microscopy: Better, Faster, Cheaper
Maria Shevchuk, M.D., Associate Professor, Pathology & Lab Medicine, Weill Cornell Medical College, Cornell University
Ex vivo microscopy (EVM) is the histologic evaluation of human tissues in real time, without processing, using light of various wave lengths. Uses of EVM include: 1. intraoperative assessments and selection of most significant tissue for frozen section; 2. intraprocedural adequacy assessment of needle biopsies; 3. tissue selection for molecular/genetic studies; and 4. documentation of histology of biobanked tissues. Prompt, definitive diagnosis facilitates patient care, saving the patient and the medical system money.
Breast Margin Assessment by ex vivo Microscopy: The Crucial Role of the Pathologist in Validation
Wendy A. Wells, M.D., MSc, The E. Elizabeth French Professor and Chair, Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth; Vice President, Pathology and Laboratory Medicine Service Line, Dartmouth-Hitchcock Medical Center
Clinical uses of real-time, rapid imaging of unprocessed fresh biopsy or excisional tissue by EVM include the intra-operative assessment of tumor margins or sentinel nodes, specimen triaging for tissue bank storage, and biopsy adequacy for molecular genomic studies. The validation of biologically-based image contrast with biomarkers linked to the tissue diagnosis “gold standard” made by pathologists is critical to the successful translation of optical imaging technology to the clinical arena.
Scientific Advisory Board
– Eric F. Glassy, M.D., FCAP, Medical Director, Affiliated Pathologists Medical Group
– Liron Pantanowitz, M.D., Professor of Pathology & Biomedical Informatics, University of Pittsburgh Medical Center, Conference Chairman
– David L. Rimm, M.D., Ph.D., Professor, Pathology, Yale University
– David C. Wilbur, M.D., Professor, Pathology, Massachusetts General Hospital
Register [SAVE up $200, Register by January 6]
Final Agenda | Sponsorship & Exhibits | Present a Poster | Conference Brochure
>> Join Our New LinkedIn Group! <<
CONFERENCE-AT-A-GLANCE
OPENING KEYNOTE SESSION
IT Standardization in Digital Imaging in Pathology
Marcial García-Rojo, Ph.D., Head, Pathology Department, Hospital de Jerez de la Frontera, Ronda de Circunvalación
IN VIVO MICROSCOPY
Naked Eye to Nucleotide
Babar K. Rao, M.D., FAAD, Clinical Professor, Dermatology, Robert Wood Johnson Medical School, Rutgers University
Ex vivo Microscopy: Better, Faster, Cheaper
Maria Shevchuk, M.D., Associate Professor, Pathology & Lab Medicine, Weill Cornell Medical College, Cornell University
Breast Margin Assessment by ex vivo Microscopy: The Crucial Role of the Pathologist in Validation
Wendy A. Wells, M.D., MSc, The E. Elizabeth French Professor and Chair, Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth; Vice President, Pathology and Laboratory Medicine Service Line, Dartmouth-Hitchcock Medical Center
Improving Patient Care through a Diagnostic Collaboration Workflow
Chrystal Adams, Assistant Vice President, Product Marketing, XIFIN, Inc.
Sponsored Presentation (Opportunities Available)
PRACTICAL SKILLS FOR WSI ANALYTICS
A Hands-On Workshop
Instructors:
Ulysses G. J. Balis, M.D., FCAP, FASCP, FAIMBE, Professor, Pathology; Director, Division of Pathology Informatics; Director, Pathology Informatics Fellowship Program, Pathology, University of Michigan Health System
Chris Williams, M.D., Senior Lecturer, Informatics, Department of Pathology, University of Michigan
Presentation to be Announced
DIGITIZED CYTOLOGY AND COMPUTATIONAL PATHOLOGY
Imaging Fluorescence Flow and Mass Cytometry; New Frontiers in Cellular Analyses
Frederic I. Preffer, Ph.D., Director, Flow Cytometry, Pathology, Massachusetts General Hospital; Associate Professor, Pathology, Harvard Medical School
Three-Dimensional Imaging of Individual Cells: Use of Cell-CT Has a Variety of Potential Applications in Morphology-Based Assays
David C. Wilbur, M.D., Professor, Pathology, Massachusetts General Hospital
Deep Learning for Computational Pathology
Andrew Beck, Ph.D., Principal Investigator, Pathology, Beth Israel Deaconess Medical Center
Presentation to be Announced
Clive Taylor, M.D., Ph.D., Consulting CMO, OptraSCAN
IMAGE ANALYSIS
3D Printing in Anatomy and Surgical Pathology
John E. Tomaszewski, M.D., MASCP, Professor and Chair, Pathology and Anatomical Sciences, School of Medicine and Biomedical Sciences, State University of New York, Buffalo
The Role of Micro CT in the Imaging of Surgical Pathology Specimens
James Michaelson, Ph.D., Director, Laboratory of Quantitative Medicine, Member, Pathology and Surgery, Massachusetts General Hospital; Associate Professor, Harvard University
Emerging Opportunities for Clinically-Deployed, High-Throughput WSI Analytics: Real World Use Cases Come of Age
Ulysses G. J. Balis, M.D., FCAP, FASCP, FAIMBE, Professor of Pathology, Director, Division of Pathology Informatics; Director, Pathology Informatics Fellowship Program, Department of Pathology, University of Michigan Health System
REGULATORY AND LEGAL ISSUES AROUND DIGITAL PATHOLOGY
Digital Pathology: What Will the Regulations Bring
Esther Abels, Director, Quality and Regulatory and Medical Affairs; Emerging Businesses, Philips Digital Pathology Solutions
CAP Quantitative Image Analysis Guideline Update
Liron Pantanowitz, M.D., Professor, Pathology & Biomedical Informatics, University of Pittsburgh Medical Center (Conference Chairman)
WSI Performance Assessment to Inform Digital Pathology Diagnostic Applications
Mark Simpson, Ph.D., Senior Scientist, Laboratory of Cancer Biology and Genetics, National Cancer Institute
DIGITAL PATHOLOGY AND IMMUNOTHERAPY MARKERS
Clinical Value of Studying the Tumor Immune Microenvironment Using Multiplex Quantitative Approaches
Kurt A. Schalper, M.D., Ph.D., Assistant Professor, Pathology and Medicine (Medical Oncology), Yale School of Medicine; Director Translational Immuno-oncology Laboratory, Yale Cancer Center
Association of PDLs, Cytotoxic T Cells, and Mutational Load to Each Other and to Anti-PD-1
Janis M. Taube, M.D., Associate Professor, Dermatology, Pathology, and Oncology; Director, Dermatopathology Division and Fellowship, Johns Hopkins University School of Medicine
The Role of Digital Pathology in Assessing the Target for PD-L1 Immuno-Therapy
David L. Rimm, M.D., Ph.D., Professor, Pathology, Yale University
